muramylnac-ala-isogln-lys-tripeptide has been researched along with Cancer of Kidney in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Favaro, D; Galligioni, E; Monfardini, S; Quaia, M; Santarosa, M; Spada, A; Talamini, R | 1 |
1 other study(ies) available for muramylnac-ala-isogln-lys-tripeptide and Cancer of Kidney
| Article | Year |
|---|---|
Activation of cytolytic activity in peripheral blood monocytes of renal cancer patients against non-cultured autologous tumor cells.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Carcinoma, Renal Cell; Humans; Immunotherapy, Adoptive; Interferon-gamma; Kidney Neoplasms; Monocytes; Tumor Cells, Cultured | 1993 |